The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial
Ortner, Vinzent Kevin, Johansen, Berit, Kilov, Kim, Castillo Mondragón, Alejandro, Duvold, Tore, Kihl, Jesper, Ashcroft, Felicity J, Feuerherm, Astrid J, Pind Laugesen, Charlotte, Marcker Espersen, Maiken Lise, Manole, Ionela, Isberg, Ari Pall, Andersen, Anders Daniel, Rakvaag, Elin, Zibert, John R, Haedersdal, Merete
Published in BMJ open (05.10.2022)
Published in BMJ open (05.10.2022)
Get full text
Journal Article
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A 2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial
Ortner, Vinzent Kevin, Johansen, Berit, Kilov, Kim, Castillo Mondragón, Alejandro, Duvold, Tore, Kihl, Jesper, Ashcroft, Felicity J, Feuerherm, Astrid J, Pind Laugesen, Charlotte, Marcker Espersen, Maiken Lise, Manole, Ionela, Isberg, Ari Pall, Andersen, Anders Daniel, Rakvaag, Elin, Zibert, John R, Haedersdal, Merete
Published in BMJ open (05.10.2022)
Published in BMJ open (05.10.2022)
Get full text
Journal Article